Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector is a research paper published in mBio (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Cancer Institute
Grant: P50CA098252, R01CA237067
HHS | NIH | National Cancer Institute
Grant: R50 CA251953
NCI NIH HHS
Grant: P50 CA098252
NCI NIH HHS
Grant: R01 CA237067
National Institutes of Health
Grant: 5P50CA098252-17
SPORE in Cervical Cancer
National Institutes of Health
Grant: 5R01CA237067-05
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy
National Institutes of Health
Grant: 5R50CA251953-03
Development and Characterization of Immunotherapies for HPV-Associated Malignancies
MeSH Terms
Keywords